Olmesartan Medoxomil 10mg Tablet
Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Daewoo Pharmaceutical Co., Ltd.
MFDS item code 202002466 · Approved 2020.04.08
This product's status changed to Expired on 2025.04.08. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension
This medication is used to treat essential hypertension.
<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If further blood pressure reduction is needed, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect occurs within 2 weeks after starting treatment and reaches its maximum after approximately 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered in combination with a thiazide diuretic, such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time each day (e.g., in the morning), if possible. In patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended that treatment be started at a low dose while their condition is closely monitored. <Elderly patients> No dose adjustment is necessary when administering this drug to patients aged 65 years or older. No overall differences in efficacy or safety were observed between elderly and younger patients; however, the possibility of a more sensitive response in some elderly patients cannot be excluded. <Patients with renal impairment> The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> Use of this drug is not recommended because there is no experience with its use in patients with hepatic impairment.
Safety and efficacy in pediatric patients have not been established and use is not recommended.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately if pregnancy is confirmed. Patients who are allergic to any component of this medication, pregnant or breastfeeding, undergoing renal dialysis, suffering from severe liver disease, experiencing bile duct obstruction, or those with lactose intolerance should not take this medication. Patients with low blood volume or salt deficiency may experience hypotension; it is important to verify their condition before taking the medication and to take appropriate action if hypotensive symptoms occur. Patients with impaired renal function or those who have received kidney transplants should have their renal function and electrolyte levels monitored regularly through blood tests, and patients with renal artery stenosis should also exercise caution. This medication lowers blood pressure, which may cause dizziness, so caution is necessary when driving or operating hazardous machinery. During treatment, be careful about taking potassium-containing medications, as they may increase potassium levels in the blood, and using other antihypertensive medications may enhance the blood pressure-lowering effect. Taking this medication with lithium or non-steroidal anti-inflammatory drugs (NSAIDs) may increase the risk of renal impairment, so consultation with a healthcare professional is advised. This medication should be avoided during pregnancy as it can lead to hypotension, decreased renal function, or skeletal abnormalities in the fetus; it is important to discontinue use as soon as possible during early pregnancy. Breastfeeding women should be aware that this medication may be passed to breast milk, potentially leading to adverse symptoms in the infant, necessitating the cessation of breastfeeding or the medication. Safety and efficacy in pediatric patients have not been adequately established, so caution should be exercised when considering use in children. Elderly patients may experience elevated drug concentration, so caution is warranted when prescribing. Overdose may result in hypotension and palpitations; if symptoms are severe, immediate medical attention should be sought. This medication is believed to have a low risk of carcinogenic or genotoxic effects even with long-term use; however, if any abnormal symptoms arise during treatment, please consult a healthcare professional immediately.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is safest to store it at room temperature between 1°C and 25°C. Avoid storing in excessively hot or cold environments.
White round film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Daewoo Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
JW Pharmaceutical Corp.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
DongKook Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.